fda tirzepatide ruling 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these FDA's tirzepatide decision creates uncertainty

Many plateau responders report their weight loss accelerating within weeks of reaching therapeutic tirzepatide doses, often surpassing the rate they experienced during their best months on semaglutide

But here is what the headlines do not tell you

As of 2025, an estimated 15.5 million Americans have used injectable weight loss medications, a category that has grown approximately 300% since 2021

MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels

It is administered as a once-daily subcutaneous injection, with dose titration to 3 mg

When the ROS generation rate exceeds the clearance rate, excessive oxidation of ROS might directly damage mitochondrial lipid membranes, proteins, and mtDNA, contributing to mitochondrial dysfunction